Medications for pulmonary fibrosis: antifibrotics and immunomodulators

(1:6:52)

Antifibrotics and fatty liver drugs in the pipeline | Sanjay Bhagani, MD

(13:9)

Antifibrotics and Progressive Fibrotic ILD

(37:47)

Antifibrotics and dust-related progressive fibrotic lung diseases

(48:54)

Choosing NOT to take antifibrotic medication

(5:23)

Evolution of Antifibrotic Therapy in IPF

(3:8)

IPF Management and Antifibrotic Therapy

(56:49)

IPF Real world long term experience with antifibrotic treatment

(7:14)

Antifibrotic treatment in Pulmonary Fibrosis

(8:29)

Applying the Evidence on Antifibrotic Agents for IPF

(10:44)

Which Patients with IPF Should be on Antifibrotics? The Value of Shared Decision Making

(46)

Dr. Charlene Fell – Generic Antifibrotics: Is a Rose a Rose by Any Other Name?

(1:24:23)

Expanding the Use of Antifibrotic Therapy in Patients with PF

(5:21)

Current Perspective on Antifibrotic Therapy for Patients with IPF

(2:11)

Informing Treatment of Primary and Inflammatory Fibrosis by Understanding... | Ivan Rosas, MD

(17:29)

Pulmonary Fibrosis After COVID-19: Treatments and Transplant

(58:47)

A New Study Evaluating Pulmonary Rehabilitation Added on to Antifibrotic Therapy

(2:15)

Antifibrotics in NON IPF ILD

(1:28:11)

Exploring Antifibrotic Therapy in Patients with Autoimmune Associated ILD

(3:15)